Study the effectiveness of Hydroxyzine hydrochloride in Patients with Persistent Itching
Phase 4
- Conditions
- Health Condition 1: null- Chronic Pruritus
- Registration Number
- CTRI/2017/06/008847
- Lead Sponsor
- Dr Reddys Laboratories Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 400
Inclusion Criteria
1.Patients clinically diagnosed with chronic pruritus due to dermatological conditions where physician has taken decision to prescribe hydroxyzine hydrochloride.
2. Patients aged 18 years to 50 years who provide informed consent for data collection.
3. Patients of both sexes.
Exclusion Criteria
1. Patients with chronic pruritus due to systemic causes.
2. Patients with known hypersensitivity to hydroxyzine hydrochloride or any component of this medication.
3. Females who are pregnant or are lactating.
4. Patients on other CNS medications, or known neurological conditions.
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effectiveness of hydroxyzine hydrochloride in improving Quality of Life will be recorded using the DLQI questionnaire at the end of 12 weeks compared to baselineTimepoint: 12 weeks
- Secondary Outcome Measures
Name Time Method Effectiveness of hydroxyzine hydrochloride in improvement of pruritus, will be recorded using the 5D Itch Scale at the end of 12 weeks compared to baselineTimepoint: 12 weeks